Latest Cannabis/Marijuana News from MJBizDaily.com

MJBiz MJBizDaily.com is a must-read site for anyone that wants to know what's happening in the cannabis MSO and LP industry and below is a summary of such news related to some of the American cannabis multi-state operator (MSO) and Canadian cannabis licensed producer (LP) companies in our MunAiMarkets portfolio....

A Historical Gold:Silver Ratio Means A Much Higher Silver Price

An Introduction It's realistic to expect that silver will eventually escalate dramatically in price given its under-valuation relative to its average historical relationship with gold but the question is: "By how much?" This article applies the historical gold:silver ratios to come up with a range of prices based on specific...

Our Canadian Cannabis LP Portfolio Continued DOWN w/e Sept. 6th

An Introduction The Canadian Cannabis LP Portfolio continues to reel from the August 26th announcement by the Drug Enforcement Administration (DEA) that it had scheduled an administrative hearing for December 2nd to consider differing expert opinions on the Justice Department’s proposal that cannabis be re-classified to that of a Schedule...

Our Quantum Computing Portfolio Dropped 9.8% w/e September 6th

An Introduction Tech stocks began to plummeted last Tuesday after the ISM manufacturing index reported August figures that came in below consensus expectations. That raised fears about the strength of the economy and increased the chances that the Federal Reserve will cut interest rates. To avoid duplication and wasting the...

Our Computer Chips-Related Portfolio Was DOWN 12% w/e Sept. 6th

There are 6 segments involved in the design, material supply, fabrication,  testing, packaging, and distribution of semiconductor devices such as microprocessors, memory chips, and sensors involving multiple companies, each with their own specialized contributions. Our Computer Chips Portfolio The 27 pure-play stocks involved in the 6 segments are presented below,...

AI-focused Drug Portfolio Went DOWN 8% w/e Sept 6th

An Introduction According to research from Grand View Research, the AI-powered drug discovery process is expected to grow by a compound annual growth rate of 30% between now and 2030 and, according to Morgan Stanley, should result in as many as 50 novel therapies being brought to market by then and generate...